Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event.

STAT annotates emails physician Kerry Kennedy Meltzer received from her uncle, Robert F. Kennedy Jr., commenting on the ...

An England-wide study of over 58 million people has identified eight rare diseases that carry significantly increased risks for COVID-19-related mortality in fully vaccinated individuals.

A big step forward in COVID-19 treatment and a breakthrough for a Florida-based nonprofit blood center serving the southeast. OneBlood just became the first blood center to get full FDA approval to ...

Findings reveal fluoxetine's weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain. The analysis, led by researchers at Imperial College London and the UK Dementia Research ...

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

The collapse reflects a widespread and mounting distrust of public health authorities, and the reason for that distrust is no mystery.

A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a ...